Hypoglossal neuropathology and respiratory activity in Pompe mice

Frontiers in Physiology

Volumn JUN, Issue , 2011, Pages

  Lee, Kun Ze ^a   Qiu, Kai ^a   Sandhu, Milapjit S ^a   Elmallah, Mai K ^b   Falk, Darin J ^a,b   Lane, Michael A ^b   Reier, Paul J ^b   Byrne, Barry J ^a,b   Fuller, David D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Acid glucosidase; Brainstem; Glycogen; Hypoglossal; Pompe

Indexed keywords

EID: 84866181597     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2011.00031     Document Type: Article

References (74)

1. Ausems, M. G., Verbiest, J., Hermans, M. P., Kroos, M. A., Beemer, F. A., Wokke, J. H., Sandkuijl, L. A., Reuser, A. J., and van der Ploeg, A. T. (1999). Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counseling. Eur. J. Hum. Genet. 7,713-716.
2. Bailey, E. F., and Fregosi, R. F. (2004). Coordination of intrinsic and extrinsic tongue muscles during spontaneous breathing in the rat. J. Appl Physiol. 96, 440-449.
3. Bailey, E. F., Huang, Y. H., and Fregosi, R. F. (2006). Anatomic consequences of intrinsic tongue muscle activation. J. Appl Physiol. 101, 1377-1385.
4. Baker-Herman, T. L., Bavis, R. W., Dahlberg, J. M., Mitchell, A. Z., Wilkerson, J. E., Golder, F. J., Macfarlane, P. M., Watters, J. J., Behan, M., and Mitchell, G. S. (2010). Differential expression of respiratory long-term facilitation among inbred rat strains. Respir. Physiol Neurobiol. 170,260-267.
5. Balkowiec, A., and Katz, D. M. (1998). Brain-derived neurotrophic factor is required for normal development of the central respiratory rhythm in mice. J. Physiol .(Lond.) 510(Pt 2), 527-533.
6. Beck, M. (2009). Alglucosidase alfa: long term use in the treatment of patients with Pompe disease. Ther. Clin. Risk Manag. 5, 767-772.
7. Boscan, P., Pickering, A. E., and Paton, J. F. (2002). The nucleus of the solitary tract: an integrating station for nociceptive and cardiorespiratory afferents. Exp. Physiol. 87, 259-266.
8. Burghaus, L., Liu, W., Neuen-Jacob, E., Gempel, K., and Haupt, W. F. (2006). Glycogenesis Type II (M. Pompe). Selective failure of the respiratory musculature - a rare first symptom. Nervenarzt 77, 181-182; 185-186.
9. Burrow, T. A., Bailey, L. A., Kinnett, D. G., and Hopkin, R. J. (2010). Acute progression of neuromuscular findings in infantile Pompe disease. Pediatr. Neurol. 42, 455-458.
10. Byrne, B. J., Kishnani, P. S., Case, L. E., Merlini, L., Muller-Felber, W., Prasad,S.,andderPloeg,A. (2011a). Pompe disease: design, methodology, and early findings from the Pompe registry. Mol. Genet. Metab. 103, 1-11.
11. Byrne, B. J., Falk, D. J., Pacak, C. A., Nayak, S., Herzog, R. W., Elder, M. E., Collins, S. W., Conlon, T. J., Clement, N., Cleaver, B. D., Cloutier, D. A., Porvasnik, S. L., Islam, S., Elmallah, M. K., Martin, A., Smith, B. K., Fuller, D. D., Lawson, L. A., and Mah, C. S. (2011b). Pompe disease gene therapy. Hum. Mol Genet. 20, R61-R68.
12. Clement, D. H., and Godman, G. C. (1950). Glycogen disease resembling mongolism, cretinism, and amytonia congenita; case report and review of literature. J. Pediatr. 36, 11-30.
13. DeRuisseau, L. R., Fuller, D. D., Qiu, K., DeRuisseau, K. C., Donnelly, W. H. Jr., Mah, C., Reier, P. J., and Byrne, B. J. (2009). Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc. Natl. Acad. Sci. U.S.A. 106, 9419-9424.
14. Erickson, J. T., Shafer, G., Rossetti, M. D., Wilson, C. G., and Deneris, E. S. (2007). Arrest of 5HT neuron differentiation delays respiratory maturation and impairs neonatal homeostatic responses to environmental challenges. Respir. Physiol. Neurobiol. 159,85-101.
15. Feldman, J. L., and Del Negro, C. A. (2006). Looking for inspiration: new perspectives on respiratory rhythm. Nat. Rev. Neurosci. 7, 232-242.
16. Feldman, J. L., Mitchell, G. S., and Nattie, E. E. (2003). Breathing: rhythmicity, plasticity, chemosensitivity. Annu. Rev. Neurosci. 26, 239-266.
17. Fregosi, R. F., and Fuller, D. D. (1997). Respiratory-related control of extrinsic tongue muscle activity. Respir. Physiol. 110,295-306.
18. Fuller, D. D., Baker, T. L., Behan, M., and Mitchell, G. S. (2001). Expression of hypoglossal long-term facilitation differs between substrains of Sprague-Dawley rat. Physiol. Genomics4, 175-181.
19. Fuller, D. D., Mateika, J. H., and Fregosi, R. F. (1998). Co-activation of tongue protrudor and retractor muscles during chemoreceptor stimulation in the rat. J. Physiol. (Lond.) 507(Pt 1), 265-276.
20. Fuller, D. D., Williams, J. S., Janssen, P. L., and Fregosi, R. F. (1999). Effect of co-activation of tongue protrudor and retractor muscles on tongue movements and pharyngeal airflow mechanics in the rat. J. Physiol. (Lond.) 519(Pt 2), 601-613.
21. Gambetti, P., DiMauro, S., and Baker, L. (1971). Nervous system in Pompe's disease. Ultrastructure and biochemistry. J. Neuropathol. Exp. Neurol. 30,412-430.
22. Gestreau, C., Dutschmann, M., Obled, S., and Bianchi, A. L. (2005). Activation of XII motoneurons and premotor neurons during various oropharyngeal behaviors. Respir. Physiol. Neurobiol. 147, 159-176.
23. Guo, Y., Goldberg, S. J., and McClung, J. R. (1996). Compartmental organization of styloglossus and hyoglossus motoneurons in the hypoglossal nucleus of the rat. Brain Res. 728, 277-280.
24. Guth, L., and Watson, P. K. (1968). A correlated histochemical and quantitative study on cerebral glycogen after brain injury in the rat. Exp. Neurol. 22, 590-602.
25. Hagemans, M. L., Winkel, L. P., Hop, W. C., Reuser, A. J., van Doorn, P. A., and van der Ploeg,A. T. (2005). Disease severity in children and adults with Pompe disease related to age and disease duration. Neurology 64, 2139-2141.
26. Haley, S. M., Fragala, M. A., and Skrinar,A. M. (2003). Pompe disease and physical disability. Dev. Med. Child Neurol. 45, 618-623.
27. Hirschhorn, R. R., and Reuser, A. J. (2001). "Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency," in Metabolic and Molecular Basis of Inherited Disease, eds C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle (New York: McGrawHill), 3389-3420.
28. Hofer, M. A. (1984). Lethal respiratory disturbance in neonatal rats after arterial chemoreceptor denervation. Life Sci. 34, 489-496.
29. Hogan, G. R., Gutmann, L., Schmidt, R., and Gilbert, E. (1969). Pompe's disease. Neurology 19, 894-900.
30. Horner, R. L. (2008). Pathophysiology of obstructive sleep apnea. J. Cardiopulm. Rehabil. Prev. 28,289-298.
31. Jones, H. N., Muller, C. W., Lin, M., Banugaria, S. G., Case, L. E., Li, J. S., O'Grady, G., Heller, J. H., and Kishnani, P. S. (2010). Oropharyngeal dysphagia in infants and children with infantile Pompe disease. Dysphagia 25, 277-283.
32. Kikuchi, T., Yang, H. W., Pennybacker, M., Ichihara, N., Mizutani, M., van Hove, J. L., and Chen, Y. T. (1998). Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail. J. Clin. Invest. 101,827-833.
33. Kishnani, P. S., Corzo, D., Leslie, N. D., Gruskin, D., van der Ploeg, A., Clancy, J. P., Parini, R., Morin, G., Beck, M., Bauer, M. S., Jokic, M., Tsai, C. E., Tsai, B. W., Morgan, C., O'Meara, T., Richards, S., Tsao, E. C., and Mandel, H. (2009). Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. Pediatr. Res. 66, 329-335.
34. Kubin, L., Alheid, G. F., Zuperku, E. J., and McCrimmon, D. R. (2006). Central pathways of pulmonary and lower airway vagal afferents. J. Appl. Physiol. 101,618-627.
35. Lane, M. A., Truettner, J. S., Brunschwig, J. P., Gomez, A., Bunge, M. B., Dietrich, W D., Dziegielewska, K. M., Ek, C J., Vandeberg, J. L., and Saunders, N. R. (2007). Age-related differences in the local cellular and molecular responses to injury in developing spinal cord of the opossum, Monodelphis domestica. Eur. J. Neurosci. 25,1725-1742.
36. Lane, M. A., White, T. E., Coutts, M. A., Jones, A. L., Sandhu, M. S., Bloom, D.C., Bolser, D. C., Yates, B. J., Fuller, D. D., and Reier, P. J. (2008). Cer vical prephrenic interneurons in the normal and lesioned spinal cord of the adult rat. J. Comp. Neurol. 511, 692-709.
37. Lee, K. Z., and Fuller, D. D. (2010a). Preinspiratory and inspiratory hypoglossal motor output during hypoxia-induced plasticity in the rat. J. Appl. Physiol. 108,1187-1198.
38. Lee, K. Z., and Fuller, D. D. (2010b). Hypoxia-induced short-term potentiation of respiratory-modulated facial motor output in the rat. Respir. Physiol. Neurobiol. 173, 107-111.
39. Lee, K. Z., Fuller, D. D., Lu, I. J., Lin, J. T., and Hwang, J. C. (2007a). Neural drive to tongue protrudor and retractor muscles following pulmonary C-fiber activation. J. Appl. Physiol. 102, 434-444.
40. Lee, K. Z., Fuller, D. D., Tung, L. C., Lu, I. J., Ku, L. C., and Hwang, J. C.(2007b). Uncoupling of upper airway motor activity from phrenic bursting by positive end-expired pressure in the rat. J. Appl. Physiol. 102,878-889.
41. Lee, K. Z., Reier, P. J., and Fuller, D.D. (2009). Phrenic motoneuron discharge patterns during hypoxia-induced short-term potentiation in rats. J. Neurophysiol. 102, 2184-2193.
42. Levine, J. C., Kishnani, P. S., Chen, Y. T., Herlong, J. R., and Li, J. S. (2008). Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease. Pediatr. Cardiol. 29,1033-1042.
43. Mah, C., Pacak, C. A., Cresawn, K. O., Deruisseau, L. R., Germain, S., Lewis, M. A., Cloutier, D. A., Fuller, D. D., and Byrne, B. J. (2007). Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors. Mol. Ther. 15,501-507.
44. Mah, C. S., Falk, D. J., Germain, S. A., Kelley, J. S., Lewis, M. A., Cloutier, D. A., DeRuisseau, L. R., Conlon, T. J., Cresawn, K. O., Fraites, T. J. Jr., Campbell-Thompson, M., Fuller, D. D., and Byrne, B. J. (2010). Gelmediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease. Mol. Ther. 18, 502-510.
45. Mancall, E. L., Aponte, G. E., and Berry, R. G. (1965). Pompe's disease (diffuse glycogenosis) with neuronal storage. J. Neuropathol. Exp. Neurol. 24, 85-96.
46. Margolis, M. L., Howlett, P., Goldberg, R., Eftychiadis, A., and Levine, S. (1994). Obstructive sleep apnea syndrome in acid maltase deficiency. Chest 105, 947-949.
47. Marsden, D. (2005). Infantile onset Pompe disease: a report of physician narratives from an epidemiologic study. Genet. Med. 7,147-150.
48. Martin, J. J., de Barsy, T., van Hoof, F., and Palladini, G. (1973). Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol. 23,229-244.
49. Martini, C., Ciana, G., Benettoni, A., Katouzian, F., Severini, G. M., Bussani, R., and Bembi, B. (2001). Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2. Neurology 57, 906-908.
50. Matsui, T., Kuroda, S., Mizutani, M., Kiuchi, Y., Suzuki, K., and Ono, T. (1983). Generalized glycogen storage disease in Japanese quail (Coturnix coturnix japonica). Vet. Pathol. 20, 312-321.
51. McClung, J. R., and Goldberg, S. J. (1999). Organization of motoneurons in the dorsal hypoglossal nucleus that innervate the retrusor muscles of the tongue in the rat. Anat. Rec. 254, 222-230.
52. Mellies, U., and Lofaso, F. (2009). Pompe disease: a neuromuscular disease with respiratory muscle involvement. Respir. Med. 103,477-484.
53. Mellies, U., Stehling, F., Dohna-Schwake, C., Ragette, R., Teschler, H., and Voit, T. (2005). Respiratory failure in Pompe disease: treatment with noninvasive ventilation. Neurology 64, 1465-1467.
54. Millecamps, S., Nicolle, D., Ceballos-Picot, I., Mallet, J., and Barkats, M. (2001). Synaptic sprouting increases the uptake capacities of motoneurons in amyotrophic lateral sclerosis mice. Proc. Natl. Acad. Sci. U.S.A. 98, 7582-7587.
55. Muller, C. W., Jones, H. N., O'Grady, G., Suarez, A. H., Heller, J. H., and Kishnani, P. S. (2009). Language and speech function in children with infantile Pompe disease. J. Pediatr. Neurol. 7,147-156.
56. Nicolino, M., Byrne, B., Wraith, J. E., Leslie, N., Mandel, H., Freyer, D. R., Arnold, G. L., Pivnick, E. K., Ottinger, C. J., Robinson, P. H., Loo, J. C., Smitka, M., Jardine, P., Tatò, L., Chabrol, B., McCandless, S., Kimura, S., Mehta, L., Bali, D., Skrinar, A., Morgan, C., Rangachari, L., Corzo, D., and Kishnani, P. S. (2009). Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet. Med. 11, 210-219.
57. Onimaru, H., Kumagawa, Y., and Homma, I. (2006). Respiration-related rhythmic activity in the rostral medulla of newborn rats. J. Neurophysiol. 96, 55-61.
58. Pellegrini, N., Laforet, P., Orlikowski, D., Pellegrini, M., Caillaud, C., Eymard, B., Raphael, J. C., and Lofaso, F. (2005). Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur. Respir. J. 26,1024-1031.
59. Raben, N., Danon, M., Gilbert, A. L., Dwivedi, S., Collins, B., Thurberg, B. L., Mattaliano, R. J., Nagaraju, K., and Plotz, P. H. (2003). Enzyme replacement therapy in the mouse model of Pompe disease. Mol. Genet. Metab. 80, 159-169.
60. Raben, N., Nagaraju, K., Lee, E., Kessler, P., Byrne, B., Lee, L., LaMarca, M., King, C., Ward, J., Sauer, B., and Plotz, P. (1998). Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II.J. Biol. Chem. 273, 19086-19092.
61. Raben, N., Plotz, P., and Byrne, B. J. (2002). Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Curr. Mol. Med. 2,145-166.
62. Remmers, J. E., deGroot, W. J., Sauerland, E. K., and Anch, A. M. (1978). Pathogenesis of upper airway occlusion during sleep. J. Appl. Physiol. 44, 931-938.
63. Rohrbach, M., Klein, A., Kohli-Wiesner, A., Veraguth, D., Scheer, I., Balmer, C., Lauener, R., and Baumgartner, M. R. (2010). CRIM-negative infantile Pompe disease: 42-month treatment outcome. J. Inherit. Metab. Dis. 33,751-757.
64. Sidman, R. L., Taksir, T., Fidler, J., Zhao, M., Dodge, J. C., Passini, M. A., Raben, N., Thurberg, B. L., Cheng, S. H., and Shihabuddin, L. S. (2008). Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice. J. Neuropathol. Exp. Neurol. 67, 803-818.
65. Sugai, F., Kokunai, Y., Yamamoto, Y., Hashida, G., Shimazu, K., Mihara, M., Inoue, S., and Sakoda, S. (2010). Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease. J. Neurol. 257, 461-463.
66. Teng, Y T., Su, W. J., Hou, J. W., and Huang, S. F. (2004). Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings. Chang GungMed. J. 27, 379-384.
67. Uemura-Sumi, M., Itoh, M., and Mizuno, N. (1988). The distribution of hypoglossal motoneurons in the dog, rabbit and rat. Anat. Embryol. 177, 389-394.
68. van den Hout, H. M., Hop, W., van Diggelen, O. P., Smeitink, J. A., Smit, G. P., Poll-The, B. T., Bakker, H. D., Loonen, M. C., de Klerk, J. B., Reuser, A. J., and van der Ploeg, A. T. (2003). The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112, 332-340.
69. van den Hout, J. M., Kamphoven, J. H., Winkel, L. P., Arts, W. F., De Klerk, J. B., Loonen, M. C., Vulto, A. G., Cromme-Dijkhuis, A., Weisglas-Kuperus, N., Hop, W., van Hirtum, H., van Diggelen, O. P., Boer, M., Kroos, M. A., van Doorn, P. A., van der Voort, E., Sibbles, B., van Corven, E. J., Brakenhoff, J. P., van Hove, J., Smeitink, J. A., de Jong, G., Reuser, A. J., and van der Ploeg, A. T. (2004). Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113, e448-457.
70. Verma,S.P.,and Quiroz-Ruiz,A. (2006). Critical values for six Dixon tests for outliers in normal samples up to sizes 100, and applications in science and engineering. Revista Mexicana de Ciencias Geológicas 23, 133-161.
71. Viemari, J. C., Roux, J. C., Tryba, A. K., Saywell, V., Burnet, H., Peña, F., Zanella, S., Bévengut, M., Barthelemy-Requin, M., Herzing, L. B., Moncla, A., Mancini, J., Ramirez, J. M., Villard, L., and Hilaire, G. (2005). Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice.J. Neurosci. 25,11521-11530.
72. Wilkerson, J. E., and Mitchell, G. S. (2009). Daily intermittent hypoxia augments spinal BDNF levels, ERK phosphorylation and respiratory long-term facilitation. Exp. Neurol. 217,116-123.
73. Willemsen, M. A., Jira, P. E., Gabreels, F. J., van der Ploeg, A. T., and Smeitink, J. A. (1998). Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease. Ned Tijdschr Geneeskd 142, 1388-1392.
74. Zellweger, H.,Dark,A.,andAbu-Haidar, G. A. (1955). Glycogen disease of skeletal muscle; report of two cases and review of literature. Pediatrics 5, 715-732.